Medtronic plc (MDT) Stock Analysis 2026

Medtronic is the world's largest stand-alone medical device company, operating across Cardiovascular, Medical Surgical, Neuroscience, and Diabetes segments. The company makes pacemakers, defibrillators, spinal stimulators, surgical robots (Hugo), insulin pumps, cardiac ablation systems, and hundreds of other devices used in procedures globally. After years of portfolio complexity and execution challenges, Medtronic is simplifying its business under CEO Geoff Martha and returning to organic growth while managing a large debt load from historical acquisitions.

This chart shows how Medtronic's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Medtronic plc trades at a trailing P/E of 24.46x, generates $4.63B in free cash flow, runs a debt/equity ratio of 58.21, and converts shareholder equity into profit at a 9.8% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Wall Street analysts covering Medtronic plc currently haven't converged on a clear consensus rating, with a mean 12-month price target of $98.84 (+7.3% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

MDT is currently in a short-term uptrend, trading above its 50-day average of $85.72 and above its 200-day average of $89.78. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

MDT's investment case breaks down into 4 bull points and 4 bear points below. The bull case outlines the key reasons the stock could outperform — competitive advantages, growth catalysts, and market tailwinds. The bear case highlights the most significant risks. A strong bull case with manageable bear risks typically makes for a more compelling investment.